Spartan Fund Management’s DA32 Life Science Tech Acquisition Corp. Class A Common Stock DALS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-282,680
| Closed | -$4.05M | – | 369 |
|
|
2023
Q2 | $4.05M | Buy |
282,680
+266,537
| +1,651% | +$3.82M | 0.98% | 39 |
|
|
2023
Q1 | $163K | Buy |
16,143
+1,319
| +9% | +$13.3K | 0.08% | 158 |
|
|
2022
Q4 | $147K | Hold |
14,824
| – | – | 0.05% | 205 |
|
|
2022
Q3 | $144K | Hold |
14,824
| – | – | 0.04% | 268 |
|
|
2022
Q2 | $144K | Hold |
14,824
| – | – | 0.03% | 324 |
|
|
2022
Q1 | $181K | Buy |
+14,824
| New | +$181K | 0.03% | 316 |
|